serw-MX  [xml]  
 


    
 DeCS Categories

B03 Bacteria .
B03.250 Chlorobi .
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.337 Leukemia .
C04.557.337.539 Leukemia, Myeloid .
C04.557.337.539.775 Sarcoma, Myeloid .
C04.557.450 Neoplasms, Connective and Soft Tissue .
C04.557.450.795 Sarcoma .
C04.557.450.795.853 Sarcoma, Myeloid .
C15 Hemic and Lymphatic Diseases .
C15.378 Hematologic Diseases .
C15.378.071 Anemia .
C15.378.071.196 Anemia, Hypochromic .
D02 Organic Chemicals .
D02.886 Sulfur Compounds .
D02.886.590 Sulfones .
D02.886.590.700 Sulfonamides .
D02.886.590.700.135 Benzothiadiazines .
D02.886.590.700.135.261 Chlorothiazide .
D02.886.590.700.135.261.476 Hydrochlorothiazide .
D02.886.590.700.135.261.476.716 Trichlormethiazide .
D02.886.655 Thiazides .
D02.886.655.500 Benzothiadiazines .
D02.886.655.500.261 Chlorothiazide .
D02.886.655.500.261.476 Hydrochlorothiazide .
D02.886.655.500.261.476.716 Trichlormethiazide .
D02.886.675 Thiazoles .
D02.886.675.180 Chlormethiazole .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.708 Thiazoles .
D03.383.129.708.180 Chlormethiazole .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.174 Benzothiadiazines .
D03.633.100.174.261 Chlorothiazide .
D03.633.100.174.261.476 Hydrochlorothiazide .
D03.633.100.174.261.476.716 Trichlormethiazide .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Chlorothiazide .
A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812) .
1.00
3897
 
Hydrochlorothiazide .
Dichlothiazide .
Dihydrochlorothiazide .
Esidrex .
Esidrix .
HCTZ 5279 .
HydroDIURIL .
Hypothiazide .
Oretic .
Sectrazide .
A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. .
0.71
1375641
 
Trichlormethiazide .
Aquazide .
Naqua .
Triazide .
Trichloromethiazide .
A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830) .
0.64
0195
 
Sarcoma, Myeloid .
Extramedullary Myeloid Cell Tumor .
Myeloid Cell Tumor, Extramedullary .
Chloromas .
Granulocytic Sarcoma .
Granulocytic Sarcomas .
Myeloid Sarcomas .
Sarcomas, Granulocytic .
Sarcomas, Myeloid .
Chloroma .
Myeloid Sarcoma .
Sarcoma, Granulocytic .
An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA. .
0.63
27840
 
Chlorobi .
Bacteria, Green Sulfur .
Chlorobiaceae .
Green Sulfur Bacteria .
A phylum of anoxygenic, phototrophic bacteria including the family Chlorobiaceae. They occur in aquatic sediments, sulfur springs, and hot springs and utilize reduced sulfur compounds instead of oxygen. .
0.60
0409
 
Chlormethiazole .
Clomethiazole .
Distraneurin .
A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors. .
0.60
3750
 
Anemia, Hypochromic .
Anemias, Hypochromic .
Chloroses .
Hypochromic Anemia .
Hypochromic Anemias .
Chlorosis .
Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) .
0.60
2267760